Celldex Therapeutics, Inc. Prepaid Expense, Noncurrent
Celldex Therapeutics, Inc. (CLDX) had Prepaid Expense, Noncurrent of $14.80 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:PrepaidExpenseNoncurrent · last filed 2026-08-06
- 2026-06-30: Prepaid Expense, Noncurrent $14.80M.
- 2026-03-31: Prepaid Expense, Noncurrent $14.80M.
- 2025-12-31: Prepaid Expense, Noncurrent $12.80M.
- 2025-09-30: Prepaid Expense, Noncurrent $9.20M.
| Period end | Prepaid Expense, Noncurrent |
|---|---|
| 2026-06-30 | $14.80M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $14.80M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $12.80M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $9.20M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $9.20M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $10.30M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $9.60M 10-K · filed 2026-02-25 |
| 2024-09-30 | $9.60M 10-Q · filed 2024-11-06 |
| 2023-12-31 | $0.00 10-K · filed 2025-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |